Apartment Investment and Management Co vs Ascendis Pharma A/S — how do they compare? Apartment Investment and Management Co trades at $2.61 (market cap $376.16M), while Ascendis Pharma A/S trades at $254.8 (market cap $16.67B). The key difference: Ascendis Pharma A/S is far larger — about 44.3× Apartment Investment and Management Co's market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, Apartment Investment and Management Co nearer its low. Which is the better fit depends on your goals.
| AIV | ASND | |
|---|---|---|
Market Cap | $376.16M | $16.67B |
Sector | Real Estate | Health |
52-Week High | $7.93 | $277.18 |
52-Week Low | $2.59 | $189.74 |
Enterprise Value | $738.32M | $17.04B |
Trailing returns across standard periods
Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development and Redevelopment
Read more on AIV →Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →